San Diego, CA, United States of America

Alisha R Simonian


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Pain Management: The Contributions of Alisha R. Simonian

Introduction

Alisha R. Simonian, an inventive force in the pharmaceutical industry, is based in San Diego, California. With a focus on enhancing pain management solutions, Simonian holds two patents that showcase her dedication to improving patient care through innovative formulations.

Latest Patents

Simonian's latest patents include cutting-edge multivesicular liposome formulations designed to deliver bupivacaine, a powerful anesthetic. These formulations provide high concentrations of bupivacaine aimed at preventing and alleviating post-surgical pain for an extended duration. The patented processes not only cover the creation of bupivacaine encapsulated multivesicular liposome formulations (BUP-MVLs) but also outline their administration as effective medicaments.

In addition, her patent related to dexamethasone focuses on multivesicular liposome formulations that encapsulate this anti-inflammatory steroid. This innovative formulation aims to provide a prolonged release of dexamethasone, ranging from three to twenty-eight days, offering new avenues for treating pain and inflammation.

Career Highlights

Alisha R. Simonian currently works at Pacira Pharmaceuticals, Inc., a leading company known for advancing pain management therapies. Her contributions to the field through her patents exemplify her commitment to developing practical solutions for persistent medical challenges.

Collaborations

Throughout her career, Simonian has collaborated with esteemed colleagues, including Louie Daniel Garcia and Soroush M. Ardekani. Their collective expertise enhances the innovative environment at Pacira Pharmaceuticals, driving forward the potential of new therapeutics.

Conclusion

Alisha R. Simonian's innovative work in developing advanced liposomal formulations represents significant progress in pain management. With her two patents, she demonstrates not only her inventiveness but also her commitment to improving the quality of life for patients. As the pharmaceutical landscape continues to evolve, Simonian's contributions will undoubtedly play a crucial role in shaping effective treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…